Alicia Brocht

2.1k total citations
12 papers, 453 citations indexed

About

Alicia Brocht is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Alicia Brocht has authored 12 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 11 papers in Neurology and 8 papers in Molecular Biology. Recurrent topics in Alicia Brocht's work include Genetic Neurodegenerative Diseases (11 papers), Mitochondrial Function and Pathology (8 papers) and Parkinson's Disease Mechanisms and Treatments (7 papers). Alicia Brocht is often cited by papers focused on Genetic Neurodegenerative Diseases (11 papers), Mitochondrial Function and Pathology (8 papers) and Parkinson's Disease Mechanisms and Treatments (7 papers). Alicia Brocht collaborates with scholars based in United States, Australia and Canada. Alicia Brocht's co-authors include David R. Lynch, Susan Perlman, George Wilmot, Bernard Ravina, Kevin Biglan, Ira Shoulson, Martin B. Delatycki, Lauren Seyer, S. H. Subramony and Katherine D. Mathews and has published in prestigious journals such as Annals of Neurology, Movement Disorders and Journal of Neurology.

In The Last Decade

Alicia Brocht

12 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alicia Brocht United States	11	366	328	208	42	30	12	453
Emilia K. Bijlsma Netherlands	10	295 0.8×	273 0.8×	141 0.7×	30 0.7×	47 1.6×	15	395
Mario Cornejo‐Olivas Peru	12	239 0.7×	195 0.6×	172 0.8×	18 0.4×	57 1.9×	58	394
José Luis Etcheverry Argentina	13	223 0.6×	182 0.6×	187 0.9×	14 0.3×	19 0.6×	26	366
Pilar Mazzetti Peru	11	239 0.7×	169 0.5×	191 0.9×	17 0.4×	40 1.3×	34	364
Humberto Moreno United States	5	483 1.3×	369 1.1×	343 1.6×	15 0.4×	74 2.5×	8	605
Marie‐Lorraine Monin France	9	211 0.6×	213 0.6×	93 0.4×	19 0.5×	29 1.0×	14	293
Tua Vinther‐Jensen Denmark	11	228 0.6×	194 0.6×	159 0.8×	18 0.4×	14 0.5×	24	391
Maria Laura Ester Bianchi Italy	12	248 0.7×	220 0.7×	155 0.7×	12 0.3×	8 0.3×	17	383
Steve Crow United Kingdom	7	517 1.4×	491 1.5×	234 1.1×	16 0.4×	117 3.9×	8	612
S. Chamberlain United Kingdom	10	270 0.7×	245 0.7×	90 0.4×	40 1.0×	17 0.6×	20	377

Countries citing papers authored by Alicia Brocht

Since Specialization

Citations

This map shows the geographic impact of Alicia Brocht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicia Brocht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicia Brocht more than expected).

Fields of papers citing papers by Alicia Brocht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alicia Brocht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicia Brocht. The network helps show where Alicia Brocht may publish in the future.

Co-authorship network of co-authors of Alicia Brocht

This figure shows the co-authorship network connecting the top 25 collaborators of Alicia Brocht. A scholar is included among the top collaborators of Alicia Brocht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicia Brocht. Alicia Brocht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Lynch, David R., Lauren Hauser, Yi Dong, et al.. (2019). Randomized, double‐blind, placebo‐controlled study of interferon‐γ 1b in Friedreich Ataxia. Annals of Clinical and Translational Neurology. 6(3). 546–553. 30 indexed citations

Hamedani, Ali G., Lauren Hauser, Susan Perlman, et al.. (2018). Longitudinal analysis of contrast acuity in Friedreich ataxia. Neurology Genetics. 4(4). e250–e250. 15 indexed citations

Shinnick, Julianna, Kimberly Schadt, Cassandra J. Strawser, et al.. (2016). Comorbid Medical Conditions in Friedreich Ataxia. Journal of Child Neurology. 31(9). 1161–1165. 6 indexed citations

Lazaropoulos, Michael P., Yina Dong, Elisia Clark, et al.. (2015). Frataxin levels in peripheral tissue in Friedreich ataxia. Annals of Clinical and Translational Neurology. 2(8). 831–842. 54 indexed citations

Seyer, Lauren, Nathaniel Greeley, Debbie Foerster, et al.. (2014). Open-label pilot study of interferon gamma-1b in Friedreich ataxia. Acta Neurologica Scandinavica. 132(1). 7–15. 41 indexed citations

Seyer, Lauren, Kristin Galetta, James Wilson, et al.. (2013). Analysis of the visual system in Friedreich ataxia. Journal of Neurology. 260(9). 2362–2369. 43 indexed citations

Dorsey, E. Ray, Alicia Brocht, Kristin C. Darwin, et al.. (2013). Depressed Mood and Suicidality in Individuals Exposed to Tetrabenazine in a Large Huntington Disease Observational Study. Journal of Huntington s Disease. 2(4). 509–515. 18 indexed citations

Regner, Sean R., Nicholas S. Wilcox, Lisa S. Friedman, et al.. (2012). Friedreich Ataxia Clinical Outcome Measures. Journal of Child Neurology. 27(9). 1152–1158. 36 indexed citations

Evans‐Galea, Marguerite V., Simone M. Rowley, Louise A. Corben, et al.. (2011). FXN methylation predicts expression and clinical outcome in Friedreich ataxia. Annals of Neurology. 71(4). 487–497. 93 indexed citations

10.

Dorsey, Ray, Kevin Biglan, Shirley Eberly, et al.. (2011). Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study. PLoS Currents. 3. RRN1283–RRN1283. 11 indexed citations

11.

Ravina, Bernard, Megan Romer, Radu Constantinescu, et al.. (2008). The relationship between CAG repeat length and clinical progression in Huntington's disease. Movement Disorders. 23(9). 1223–1227. 70 indexed citations

12.

Elm, Jordan J., Cornelia Kamp, Barbara C. Tilley, et al.. (2007). Self‐reported adherence versus pill count in Parkinson's disease: The NET‐PD experience. Movement Disorders. 22(6). 822–827. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact